Recent developments of interest in cardiovascular medicine
Panelists acknowledge difficulty generating stronger data in ultra-rare disease
Agency appears unswayed by mitochondria-targeting drug for rare cardioskeletal disease
Only a minority of patients adhered to SUNTRAC screening recommendations